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Ordered Expression of Desmosomal Cadherins During Development 
King et al (p. 531) have demonstrated that expression of the type 1 
desmocollin in mouse epithelium is closely linked to the degree of 
keratinization in the epidermis and tongue and occurs within a 
limited "window" of time during development. Type I desmocollin 
(DSCl) is restricted to the more highly differentiated layers of 
keratinizing epithelia, suggesting that DSC1 might be involved in 
• the fornlation of the stratum corneum. Since the stratum corneum 
is not present in early embryogenesis, this led the authors to 
exanrine DSCI in stages of development. First, they isolated and 
sequenced full length mouse DSC1 cDNA clones. Next, they 
examined DSC1 message in mouse embryos by ill sitll hybridization 
and monitored protein expression with monoclonal antibodies. In 
the epidermis, DSCI message was present at 15.5 days of embry-
onic development, when the epithelium had stratified but was not 
yet keratinized . DSC1 protein was expressed earliest in the outer-
most cell layers just before they started to flatten and form a stratum 
corneum. In the tongue, DSCI m essage and protein were detected 
at 17.5 days, a time coinciding with the formation of the keratin-
izing ftliform papillae. Type 1 desmogleill (DSG1), thought to be a 
"partner" of type I desmocollill in the desmosomes of keratinizing 
epithelia, was co-expressed with the DSC1 during development, 
but DSGI transcripts were always expressed before DSC1 tran-
scripts. The rather strict temporal limitation in expression of DSC1 
indicates precise regulation of expression and suggests that produc-
tion of this protein could be required for subsequent expression of 
other proteins necessary for the keratinization of epithelia . 
Two Different Pathways in Immunosuppression by UVB 
Beissert et al (p. 553) present data indicating that IL-I0 is 
involved in UV -induced immunosuppression of delayed-type 
hypersensitivity, but not in suppression of contact allergy 
als o produced by UVB . Release of IL-10 from ke ratinocytes 
exposed to UVB radiation is thought to be a key event in 
sys temic immunosuppression produced by UVB. UVB radiation 
and IL-10 share similar experimental effects, and systemic 
immunosuppression after UV treatment ca n be reduced by 
neutralizing antibodies to IL-10. To further study the role of 
IL-I 0 in immunosuppression , the investigators irradiated normal 
and IL-10-deficient mice with a single dos e of UVB before 
sensitization either to alloantigens, in the form of inj ected 
allogeneic spleen celis, to test for delayed-type hypersensitivity, or to 
contact antigens. Mter UVB exposure, IL-10-deficient mice, unlike 
nomlal mice, showed no blunting of the delayed hypersensivity 
response induced by challenge injection of allogeneic spleen cells into 
a foot pad. The response to contact allergen, however, was subst<1l1-
tially reduced. The results indicate that IL-I0 may m ediate UVB-
induced suppression of delayed-type hypersensitivity inU11Une re-
sponses, but not inhibition of contact hypersensitivity responses. Other 
mediators must be involved in UVB-induced suppression of contact 
allergy. 
More Proteins £i·om Staphylococcus aureus May Trigger or Worsen Skin Disease 
Ezepchuk ct (// (p . 603) show that staphylococcal proteins can 
cause the release of TNF-a from keratinocytes. Proteins from 
StaphylococCIIs all"CIlS, long known to contaminate les ions of 
psoriasis and atopic dermatitis, are known to be able to partici-
pa te directly in immunologic stimulation in thes e two diseases. 
In psoriasis, superantigens can directly activate lymp hocytes of 
restricted V{3 specificities and may exacerbate the disease. In 
atopic dermatitis, IgE specific for staphyloco ccal superantigen 
may mediate the immediate hypersensitivity component of 
atopy. Since it had already been shown that both ultra violet 
radiation and superantigens can ca use keratinocytes to release 
TNF-a, Ezepchuk ct al asked whether other staphylococcal 
agents might also trigger di sease by effectin g th e release of 
cytokin es from keratinocytes. The investigators found that three 
classes of proteins can indeed cause release of TNF-a fi'om 
keratinocytes ill vitro. The three types of proteins, superantigenic 
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toxins, a thermolabile toxin that may be the staphylococcal 
a-toxin , and prote in A, were all id entified in cultures of 
sta ph ylococc i isolated from uninfected lesion s of patients with 
TI-IE J ou r~NAL OF INVESTIGATIVE DERMATOLOGY 
psoriasis and atopic dermatiti s. Bacteria l co lo nizati on and release 
of TN F-a, and perhaps other cytokin es, ma y be triggers or may 
ca use pe rsistence of di sease in other skin condition s as well. 
Many Molecular Signaling Events Can Be Detected During Early Stages of Skin 
Appendage Fon-nation 
Progress in Drosophila genetics in the pa st decade has led to th e 
identification of molecul es essential for morphogenesis. These 
molecules 'include segment polarity genes, hom eobox genes, 
growth facto rs, homologs of human oncogenes or tumor suppres-
sors, and others. T hese genes are involved in the formulation and 
phenotypi c determination of Drosophila segments and epithelial 
appenda ges. This seminal work, crowned by awarding of the Nobel 
Prize in Physiology and M edicine to Nlisslein-Volhard, Wieschau, 
and Lewis in 1996, led Dr. C hu ong's research group (p . 639) to ask 
w hether the vertebrate counterparts of these mol ecul es are also 
in volved in the formation of epithelial appendages. To explore this 
possibility, they used feather developm ent as a model because of its 
accessibility to experimental manipulation . They separated the 
epithelium fro m developing chicken skin, rotated it, and then 
p laced it back on the mesenchym e. By culturing this recombined 
explant, they were able to follow the regeneration of new feather 
buds and also, simultaneously, the appearance of these candidate 
signaling molecules with ill sitll hybridization of the whole skin. 
The results provide an overview of signalin g mo lecules during the 
early stages of feather development and show the interdependence 
of the epithelium and m esenchyme in their expression. The order 
of reappearance of the signalin g genes is (i) FGFs and BMP 
(growth factors); (ii) Shh and wnt 7a (segment polarity genes) ; (iii) 
Msx-l and Msx2 (Msh homeobox genes); (iv) Hos (Hox ho-
meobox genes) and the adhesion molecule NCAM. The data can 
be easily extrapolated to the study of mammalian hair. With thi 
blueprint in hand , Dr. Chuong's group plans to examine specific 
functions of each molecule in the early stages of skin appendage 
m orphogenesis. This lin e of research may accelerate our under-
standing in the molecular basis of skin appendage induction and 
regeneration and may be highly relevant to the control of hair 
growth. 
Do Laboratory Abnormalities Reflect Clinical Symptoms in Diseases with Defective DNA Repair? 
Moriwaki et al (p. 647) report the paradoxical finding that DNA 
repair abnormalities characteristic of severe xeroderma pigmen to-
sum (XP) are present in a unusual patient with mild clinical features 
of X P and profo und features of Cockayne syndrome (CS). XP and 
CS, two rare, recessive diseases with sun sensitivity and de fective 
DNA repair, have been found to coexist in less than a dozen 
patients, patients described as having the XP/CS complex. The 
child in this study had severe CS, died at the age of six weighing 
on ly 14 .5 pounds, and had mild XP type pigmentation but no skin 
cancel·s. ·In studies of this patient's fibroblasts, some of the cellul ar 
abnormalities, such as marked hypersensitivity to killing by UV , 
we re characteristi c of both XP and CS. T he boy's cells had several 
XP-speci fi c abnormalities, however, including grea tl y redu ced 
DNA repair, and were shown to be in the rare XP complementation 
group G-a group in which 2 other patients with the XP/CS complex 
have already been desc';bed. T he finding that severe XP- type cellular 
DNA repair abnol111alities do not necessali)y result in severe XP 
symptoms suggests additional complex:ity in the development of the 
clinical phenotype, complicating our understanding ofXP . In addition. 
the finding oflinkage ofXP and CS symptoms in a third patient in XP 
complementation group G suggests that the fi.ll1ctioning of the xp- G 
gene may be related both to XP features of defective DNA repair and 
also to CS features of abnormal transc';ption. T he " disconnect" 
between the clinical and laboratory features of XP in this WlUSUa! 
patient may open an important avenue for better understanding of the 
pathogenesis of XP. 
